In conclusion, this study verified the presence of CD11b+CD33+HLA−DR− blasts which resembled MDSC in the BM of newly diagnosed AML patients and demonstrated their ability to suppress the immune functions of T cells by increasing iNOS and ARG1 expression. Here, NOS2 is linked to acute myeloid leukemia.